\VIA EDGAR
October 30, 2015
Mr. Jim B. Rosenberg
Senior Assistant Chief Accountant
Office of Healthcare and Insurance
Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Re: | USANA Health Sciences, Inc. |
| Form 10-K for the fiscal year ended January 3, 2015 |
| File No. 001-35024 |
Dear Mr. Rosenberg:
Pursuant to my telephone discussion today with Mr. Rolf Sundwall of the Securities & Exchange Commission (the “Commission”), this letter is notice that USANA Health Sciences, Inc. will submit its response to the above referenced letter to the Commission no later than Friday, November 13, 2015. Thank you.
| Sincerely, |
|
|
| USANA Health Sciences, Inc. |
|
|
| /s/ Josh Foukas |
|
|
| Josh Foukas |
| Vice President of Legal |
| and Investor Relations |
USANA Health Sciences, Inc. 3838 West Parkway Blvd., Salt Lake City, Utah 84120-6336
USANA.com